MOL THER-NUCL ACIDS 润色咨询

Molecular Therapy-Nucleic Acids

出版年份：暂无数据 年文章数：1600 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：7.2% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1071305, encodeId=bd6910e130508, content=with editor 整整两个月了，一点消息都没有，发邮件给杂志社也没有人回应，有人和我一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0885497690, createdName=ms7000001021086103, createdTime=Thu Nov 18 09:14:20 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890776, encodeId=9fc9890e769e, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：7月份投的Molecular Therapy ，编辑说研究偏向基因治疗，建议改投姊妹杂志MTNA，于是改投。中间一次小修，今天收到通知接收！比较顺利，做的比较全，机制，在体验证都做了，审稿人比较认可，小修了一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/27/c46a23a4fdf73ffb670608d86a933046.jpg, createdBy=cfaa1692461, createdName=SCI hunter , createdTime=Fri Oct 09 12:40:14 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192335, encodeId=1a21119233585, content=垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f196166226, createdName=ms9000001912630615, createdTime=Fri Feb 11 14:57:11 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191533, encodeId=28941191533df, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：很慢，基本历时9月余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf9a6160948, createdName=ms2000001136398144, createdTime=Wed Feb 09 21:27:23 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180906, encodeId=bb4f118090683, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：这个杂志超级垃圾 一审六个月 修一个月 二审一个月 二修一个月 拒了； 全程耗费一年，没有任何有意义的意见，建议各位老铁不要再投。是个垃圾不能再垃圾的杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95db5541159, createdName=阳关月, createdTime=Wed Jan 05 15:52:29 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179789, encodeId=51ea11e978932, content=European Review for Medical and Pharmacological Sciences这个专门卖文章的杂志都不预警，预警这个，收了多少钱，呵呵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05952206955, createdName=739976260_99249234, createdTime=Sun Jan 02 14:06:10 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179462, encodeId=1f4c11e94621b, content=投了将近一个礼拜了稿号是MTNA-D-21-01775，状态还是submitted哎，上了预警名单，现在还能撤回嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Sat Jan 01 02:00:36 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179651, encodeId=2c5a11e965187, content=刚投一篇，under review已经1个月了，现在被预警了，好慌啊，也不知道要不要撤下来重新投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=517c5541105, createdName=齐小丹, createdTime=Sat Jan 01 22:23:53 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063270, encodeId=398010632e0d7, content=被吉大一院列为水刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Sat Oct 23 22:23:01 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179259, encodeId=c34c11e925988, content=进了今年的中科院高预警名单，哎，刚投的一篇还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Fri Dec 31 13:15:46 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2021-11-18 ms7000001021086103

    with editor 整整两个月了，一点消息都没有，发邮件给杂志社也没有人回应，有人和我一样吗？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1071305, encodeId=bd6910e130508, content=with editor 整整两个月了，一点消息都没有，发邮件给杂志社也没有人回应，有人和我一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0885497690, createdName=ms7000001021086103, createdTime=Thu Nov 18 09:14:20 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890776, encodeId=9fc9890e769e, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：7月份投的Molecular Therapy ，编辑说研究偏向基因治疗，建议改投姊妹杂志MTNA，于是改投。中间一次小修，今天收到通知接收！比较顺利，做的比较全，机制，在体验证都做了，审稿人比较认可，小修了一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/27/c46a23a4fdf73ffb670608d86a933046.jpg, createdBy=cfaa1692461, createdName=SCI hunter , createdTime=Fri Oct 09 12:40:14 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192335, encodeId=1a21119233585, content=垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f196166226, createdName=ms9000001912630615, createdTime=Fri Feb 11 14:57:11 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191533, encodeId=28941191533df, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：很慢，基本历时9月余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf9a6160948, createdName=ms2000001136398144, createdTime=Wed Feb 09 21:27:23 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180906, encodeId=bb4f118090683, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：这个杂志超级垃圾 一审六个月 修一个月 二审一个月 二修一个月 拒了； 全程耗费一年，没有任何有意义的意见，建议各位老铁不要再投。是个垃圾不能再垃圾的杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95db5541159, createdName=阳关月, createdTime=Wed Jan 05 15:52:29 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179789, encodeId=51ea11e978932, content=European Review for Medical and Pharmacological Sciences这个专门卖文章的杂志都不预警，预警这个，收了多少钱，呵呵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05952206955, createdName=739976260_99249234, createdTime=Sun Jan 02 14:06:10 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179462, encodeId=1f4c11e94621b, content=投了将近一个礼拜了稿号是MTNA-D-21-01775，状态还是submitted哎，上了预警名单，现在还能撤回嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Sat Jan 01 02:00:36 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179651, encodeId=2c5a11e965187, content=刚投一篇，under review已经1个月了，现在被预警了，好慌啊，也不知道要不要撤下来重新投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=517c5541105, createdName=齐小丹, createdTime=Sat Jan 01 22:23:53 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063270, encodeId=398010632e0d7, content=被吉大一院列为水刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Sat Oct 23 22:23:01 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179259, encodeId=c34c11e925988, content=进了今年的中科院高预警名单，哎，刚投的一篇还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Fri Dec 31 13:15:46 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2020-10-09 SCI hunter

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：7月份投的Molecular Therapy ，编辑说研究偏向基因治疗，建议改投姊妹杂志MTNA，于是改投。中间一次小修，今天收到通知接收！比较顺利，做的比较全，机制，在体验证都做了，审稿人比较认可，小修了一些小问题。

    12

    展开12条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1071305, encodeId=bd6910e130508, content=with editor 整整两个月了，一点消息都没有，发邮件给杂志社也没有人回应，有人和我一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0885497690, createdName=ms7000001021086103, createdTime=Thu Nov 18 09:14:20 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890776, encodeId=9fc9890e769e, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：7月份投的Molecular Therapy ，编辑说研究偏向基因治疗，建议改投姊妹杂志MTNA，于是改投。中间一次小修，今天收到通知接收！比较顺利，做的比较全，机制，在体验证都做了，审稿人比较认可，小修了一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/27/c46a23a4fdf73ffb670608d86a933046.jpg, createdBy=cfaa1692461, createdName=SCI hunter , createdTime=Fri Oct 09 12:40:14 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192335, encodeId=1a21119233585, content=垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f196166226, createdName=ms9000001912630615, createdTime=Fri Feb 11 14:57:11 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191533, encodeId=28941191533df, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：很慢，基本历时9月余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf9a6160948, createdName=ms2000001136398144, createdTime=Wed Feb 09 21:27:23 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180906, encodeId=bb4f118090683, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：这个杂志超级垃圾 一审六个月 修一个月 二审一个月 二修一个月 拒了； 全程耗费一年，没有任何有意义的意见，建议各位老铁不要再投。是个垃圾不能再垃圾的杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95db5541159, createdName=阳关月, createdTime=Wed Jan 05 15:52:29 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179789, encodeId=51ea11e978932, content=European Review for Medical and Pharmacological Sciences这个专门卖文章的杂志都不预警，预警这个，收了多少钱，呵呵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05952206955, createdName=739976260_99249234, createdTime=Sun Jan 02 14:06:10 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179462, encodeId=1f4c11e94621b, content=投了将近一个礼拜了稿号是MTNA-D-21-01775，状态还是submitted哎，上了预警名单，现在还能撤回嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Sat Jan 01 02:00:36 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179651, encodeId=2c5a11e965187, content=刚投一篇，under review已经1个月了，现在被预警了，好慌啊，也不知道要不要撤下来重新投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=517c5541105, createdName=齐小丹, createdTime=Sat Jan 01 22:23:53 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063270, encodeId=398010632e0d7, content=被吉大一院列为水刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Sat Oct 23 22:23:01 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179259, encodeId=c34c11e925988, content=进了今年的中科院高预警名单，哎，刚投的一篇还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Fri Dec 31 13:15:46 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2022-02-11 ms9000001912630615

    垃圾

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1071305, encodeId=bd6910e130508, content=with editor 整整两个月了，一点消息都没有，发邮件给杂志社也没有人回应，有人和我一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0885497690, createdName=ms7000001021086103, createdTime=Thu Nov 18 09:14:20 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890776, encodeId=9fc9890e769e, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：7月份投的Molecular Therapy ，编辑说研究偏向基因治疗，建议改投姊妹杂志MTNA，于是改投。中间一次小修，今天收到通知接收！比较顺利，做的比较全，机制，在体验证都做了，审稿人比较认可，小修了一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/27/c46a23a4fdf73ffb670608d86a933046.jpg, createdBy=cfaa1692461, createdName=SCI hunter , createdTime=Fri Oct 09 12:40:14 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192335, encodeId=1a21119233585, content=垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f196166226, createdName=ms9000001912630615, createdTime=Fri Feb 11 14:57:11 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191533, encodeId=28941191533df, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：很慢，基本历时9月余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf9a6160948, createdName=ms2000001136398144, createdTime=Wed Feb 09 21:27:23 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180906, encodeId=bb4f118090683, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：这个杂志超级垃圾 一审六个月 修一个月 二审一个月 二修一个月 拒了； 全程耗费一年，没有任何有意义的意见，建议各位老铁不要再投。是个垃圾不能再垃圾的杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95db5541159, createdName=阳关月, createdTime=Wed Jan 05 15:52:29 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179789, encodeId=51ea11e978932, content=European Review for Medical and Pharmacological Sciences这个专门卖文章的杂志都不预警，预警这个，收了多少钱，呵呵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05952206955, createdName=739976260_99249234, createdTime=Sun Jan 02 14:06:10 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179462, encodeId=1f4c11e94621b, content=投了将近一个礼拜了稿号是MTNA-D-21-01775，状态还是submitted哎，上了预警名单，现在还能撤回嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Sat Jan 01 02:00:36 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179651, encodeId=2c5a11e965187, content=刚投一篇，under review已经1个月了，现在被预警了，好慌啊，也不知道要不要撤下来重新投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=517c5541105, createdName=齐小丹, createdTime=Sat Jan 01 22:23:53 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063270, encodeId=398010632e0d7, content=被吉大一院列为水刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Sat Oct 23 22:23:01 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179259, encodeId=c34c11e925988, content=进了今年的中科院高预警名单，哎，刚投的一篇还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Fri Dec 31 13:15:46 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2022-02-09 ms2000001136398144

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享：很慢，基本历时9月余

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1071305, encodeId=bd6910e130508, content=with editor 整整两个月了，一点消息都没有，发邮件给杂志社也没有人回应，有人和我一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0885497690, createdName=ms7000001021086103, createdTime=Thu Nov 18 09:14:20 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890776, encodeId=9fc9890e769e, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：7月份投的Molecular Therapy ，编辑说研究偏向基因治疗，建议改投姊妹杂志MTNA，于是改投。中间一次小修，今天收到通知接收！比较顺利，做的比较全，机制，在体验证都做了，审稿人比较认可，小修了一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/27/c46a23a4fdf73ffb670608d86a933046.jpg, createdBy=cfaa1692461, createdName=SCI hunter , createdTime=Fri Oct 09 12:40:14 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192335, encodeId=1a21119233585, content=垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f196166226, createdName=ms9000001912630615, createdTime=Fri Feb 11 14:57:11 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191533, encodeId=28941191533df, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：很慢，基本历时9月余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf9a6160948, createdName=ms2000001136398144, createdTime=Wed Feb 09 21:27:23 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180906, encodeId=bb4f118090683, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：这个杂志超级垃圾 一审六个月 修一个月 二审一个月 二修一个月 拒了； 全程耗费一年，没有任何有意义的意见，建议各位老铁不要再投。是个垃圾不能再垃圾的杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95db5541159, createdName=阳关月, createdTime=Wed Jan 05 15:52:29 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179789, encodeId=51ea11e978932, content=European Review for Medical and Pharmacological Sciences这个专门卖文章的杂志都不预警，预警这个，收了多少钱，呵呵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05952206955, createdName=739976260_99249234, createdTime=Sun Jan 02 14:06:10 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179462, encodeId=1f4c11e94621b, content=投了将近一个礼拜了稿号是MTNA-D-21-01775，状态还是submitted哎，上了预警名单，现在还能撤回嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Sat Jan 01 02:00:36 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179651, encodeId=2c5a11e965187, content=刚投一篇，under review已经1个月了，现在被预警了，好慌啊，也不知道要不要撤下来重新投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=517c5541105, createdName=齐小丹, createdTime=Sat Jan 01 22:23:53 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063270, encodeId=398010632e0d7, content=被吉大一院列为水刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Sat Oct 23 22:23:01 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179259, encodeId=c34c11e925988, content=进了今年的中科院高预警名单，哎，刚投的一篇还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Fri Dec 31 13:15:46 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2022-01-05 阳关月

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向：肿瘤
    经验分享：这个杂志超级垃圾 一审六个月 修一个月 二审一个月 二修一个月 拒了； 全程耗费一年，没有任何有意义的意见，建议各位老铁不要再投。是个垃圾不能再垃圾的杂志了

    5

    展开5条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1071305, encodeId=bd6910e130508, content=with editor 整整两个月了，一点消息都没有，发邮件给杂志社也没有人回应，有人和我一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0885497690, createdName=ms7000001021086103, createdTime=Thu Nov 18 09:14:20 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890776, encodeId=9fc9890e769e, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：7月份投的Molecular Therapy ，编辑说研究偏向基因治疗，建议改投姊妹杂志MTNA，于是改投。中间一次小修，今天收到通知接收！比较顺利，做的比较全，机制，在体验证都做了，审稿人比较认可，小修了一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/27/c46a23a4fdf73ffb670608d86a933046.jpg, createdBy=cfaa1692461, createdName=SCI hunter , createdTime=Fri Oct 09 12:40:14 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192335, encodeId=1a21119233585, content=垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f196166226, createdName=ms9000001912630615, createdTime=Fri Feb 11 14:57:11 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191533, encodeId=28941191533df, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：很慢，基本历时9月余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf9a6160948, createdName=ms2000001136398144, createdTime=Wed Feb 09 21:27:23 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180906, encodeId=bb4f118090683, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：这个杂志超级垃圾 一审六个月 修一个月 二审一个月 二修一个月 拒了； 全程耗费一年，没有任何有意义的意见，建议各位老铁不要再投。是个垃圾不能再垃圾的杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95db5541159, createdName=阳关月, createdTime=Wed Jan 05 15:52:29 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179789, encodeId=51ea11e978932, content=European Review for Medical and Pharmacological Sciences这个专门卖文章的杂志都不预警，预警这个，收了多少钱，呵呵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05952206955, createdName=739976260_99249234, createdTime=Sun Jan 02 14:06:10 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179462, encodeId=1f4c11e94621b, content=投了将近一个礼拜了稿号是MTNA-D-21-01775，状态还是submitted哎，上了预警名单，现在还能撤回嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Sat Jan 01 02:00:36 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179651, encodeId=2c5a11e965187, content=刚投一篇，under review已经1个月了，现在被预警了，好慌啊，也不知道要不要撤下来重新投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=517c5541105, createdName=齐小丹, createdTime=Sat Jan 01 22:23:53 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063270, encodeId=398010632e0d7, content=被吉大一院列为水刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Sat Oct 23 22:23:01 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179259, encodeId=c34c11e925988, content=进了今年的中科院高预警名单，哎，刚投的一篇还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Fri Dec 31 13:15:46 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2022-01-02 739976260_99249234

    European Review for Medical and Pharmacological Sciences这个专门卖文章的杂志都不预警，预警这个，收了多少钱，呵呵。

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1071305, encodeId=bd6910e130508, content=with editor 整整两个月了，一点消息都没有，发邮件给杂志社也没有人回应，有人和我一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0885497690, createdName=ms7000001021086103, createdTime=Thu Nov 18 09:14:20 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890776, encodeId=9fc9890e769e, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：7月份投的Molecular Therapy ，编辑说研究偏向基因治疗，建议改投姊妹杂志MTNA，于是改投。中间一次小修，今天收到通知接收！比较顺利，做的比较全，机制，在体验证都做了，审稿人比较认可，小修了一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/27/c46a23a4fdf73ffb670608d86a933046.jpg, createdBy=cfaa1692461, createdName=SCI hunter , createdTime=Fri Oct 09 12:40:14 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192335, encodeId=1a21119233585, content=垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f196166226, createdName=ms9000001912630615, createdTime=Fri Feb 11 14:57:11 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191533, encodeId=28941191533df, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：很慢，基本历时9月余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf9a6160948, createdName=ms2000001136398144, createdTime=Wed Feb 09 21:27:23 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180906, encodeId=bb4f118090683, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：这个杂志超级垃圾 一审六个月 修一个月 二审一个月 二修一个月 拒了； 全程耗费一年，没有任何有意义的意见，建议各位老铁不要再投。是个垃圾不能再垃圾的杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95db5541159, createdName=阳关月, createdTime=Wed Jan 05 15:52:29 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179789, encodeId=51ea11e978932, content=European Review for Medical and Pharmacological Sciences这个专门卖文章的杂志都不预警，预警这个，收了多少钱，呵呵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05952206955, createdName=739976260_99249234, createdTime=Sun Jan 02 14:06:10 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179462, encodeId=1f4c11e94621b, content=投了将近一个礼拜了稿号是MTNA-D-21-01775，状态还是submitted哎，上了预警名单，现在还能撤回嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Sat Jan 01 02:00:36 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179651, encodeId=2c5a11e965187, content=刚投一篇，under review已经1个月了，现在被预警了，好慌啊，也不知道要不要撤下来重新投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=517c5541105, createdName=齐小丹, createdTime=Sat Jan 01 22:23:53 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063270, encodeId=398010632e0d7, content=被吉大一院列为水刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Sat Oct 23 22:23:01 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179259, encodeId=c34c11e925988, content=进了今年的中科院高预警名单，哎，刚投的一篇还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Fri Dec 31 13:15:46 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2022-01-01 wsasdeffgcf

    投了将近一个礼拜了稿号是MTNA-D-21-01775，状态还是submitted哎，上了预警名单，现在还能撤回嘛

    3

    展开3条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1071305, encodeId=bd6910e130508, content=with editor 整整两个月了，一点消息都没有，发邮件给杂志社也没有人回应，有人和我一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0885497690, createdName=ms7000001021086103, createdTime=Thu Nov 18 09:14:20 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890776, encodeId=9fc9890e769e, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：7月份投的Molecular Therapy ，编辑说研究偏向基因治疗，建议改投姊妹杂志MTNA，于是改投。中间一次小修，今天收到通知接收！比较顺利，做的比较全，机制，在体验证都做了，审稿人比较认可，小修了一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/27/c46a23a4fdf73ffb670608d86a933046.jpg, createdBy=cfaa1692461, createdName=SCI hunter , createdTime=Fri Oct 09 12:40:14 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192335, encodeId=1a21119233585, content=垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f196166226, createdName=ms9000001912630615, createdTime=Fri Feb 11 14:57:11 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191533, encodeId=28941191533df, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：很慢，基本历时9月余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf9a6160948, createdName=ms2000001136398144, createdTime=Wed Feb 09 21:27:23 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180906, encodeId=bb4f118090683, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：这个杂志超级垃圾 一审六个月 修一个月 二审一个月 二修一个月 拒了； 全程耗费一年，没有任何有意义的意见，建议各位老铁不要再投。是个垃圾不能再垃圾的杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95db5541159, createdName=阳关月, createdTime=Wed Jan 05 15:52:29 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179789, encodeId=51ea11e978932, content=European Review for Medical and Pharmacological Sciences这个专门卖文章的杂志都不预警，预警这个，收了多少钱，呵呵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05952206955, createdName=739976260_99249234, createdTime=Sun Jan 02 14:06:10 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179462, encodeId=1f4c11e94621b, content=投了将近一个礼拜了稿号是MTNA-D-21-01775，状态还是submitted哎，上了预警名单，现在还能撤回嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Sat Jan 01 02:00:36 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179651, encodeId=2c5a11e965187, content=刚投一篇，under review已经1个月了，现在被预警了，好慌啊，也不知道要不要撤下来重新投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=517c5541105, createdName=齐小丹, createdTime=Sat Jan 01 22:23:53 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063270, encodeId=398010632e0d7, content=被吉大一院列为水刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Sat Oct 23 22:23:01 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179259, encodeId=c34c11e925988, content=进了今年的中科院高预警名单，哎，刚投的一篇还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Fri Dec 31 13:15:46 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2022-01-01 齐小丹

    刚投一篇，under review已经1个月了，现在被预警了，好慌啊，也不知道要不要撤下来重新投

    4

    展开4条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1071305, encodeId=bd6910e130508, content=with editor 整整两个月了，一点消息都没有，发邮件给杂志社也没有人回应，有人和我一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0885497690, createdName=ms7000001021086103, createdTime=Thu Nov 18 09:14:20 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890776, encodeId=9fc9890e769e, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：7月份投的Molecular Therapy ，编辑说研究偏向基因治疗，建议改投姊妹杂志MTNA，于是改投。中间一次小修，今天收到通知接收！比较顺利，做的比较全，机制，在体验证都做了，审稿人比较认可，小修了一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/27/c46a23a4fdf73ffb670608d86a933046.jpg, createdBy=cfaa1692461, createdName=SCI hunter , createdTime=Fri Oct 09 12:40:14 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192335, encodeId=1a21119233585, content=垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f196166226, createdName=ms9000001912630615, createdTime=Fri Feb 11 14:57:11 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191533, encodeId=28941191533df, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：很慢，基本历时9月余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf9a6160948, createdName=ms2000001136398144, createdTime=Wed Feb 09 21:27:23 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180906, encodeId=bb4f118090683, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：这个杂志超级垃圾 一审六个月 修一个月 二审一个月 二修一个月 拒了； 全程耗费一年，没有任何有意义的意见，建议各位老铁不要再投。是个垃圾不能再垃圾的杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95db5541159, createdName=阳关月, createdTime=Wed Jan 05 15:52:29 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179789, encodeId=51ea11e978932, content=European Review for Medical and Pharmacological Sciences这个专门卖文章的杂志都不预警，预警这个，收了多少钱，呵呵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05952206955, createdName=739976260_99249234, createdTime=Sun Jan 02 14:06:10 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179462, encodeId=1f4c11e94621b, content=投了将近一个礼拜了稿号是MTNA-D-21-01775，状态还是submitted哎，上了预警名单，现在还能撤回嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Sat Jan 01 02:00:36 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179651, encodeId=2c5a11e965187, content=刚投一篇，under review已经1个月了，现在被预警了，好慌啊，也不知道要不要撤下来重新投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=517c5541105, createdName=齐小丹, createdTime=Sat Jan 01 22:23:53 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063270, encodeId=398010632e0d7, content=被吉大一院列为水刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Sat Oct 23 22:23:01 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179259, encodeId=c34c11e925988, content=进了今年的中科院高预警名单，哎，刚投的一篇还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Fri Dec 31 13:15:46 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2021-10-23 wy-liang

    被吉大一院列为水刊了

    10

    展开10条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1071305, encodeId=bd6910e130508, content=with editor 整整两个月了，一点消息都没有，发邮件给杂志社也没有人回应，有人和我一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0885497690, createdName=ms7000001021086103, createdTime=Thu Nov 18 09:14:20 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890776, encodeId=9fc9890e769e, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：7月份投的Molecular Therapy ，编辑说研究偏向基因治疗，建议改投姊妹杂志MTNA，于是改投。中间一次小修，今天收到通知接收！比较顺利，做的比较全，机制，在体验证都做了，审稿人比较认可，小修了一些小问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/27/c46a23a4fdf73ffb670608d86a933046.jpg, createdBy=cfaa1692461, createdName=SCI hunter , createdTime=Fri Oct 09 12:40:14 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192335, encodeId=1a21119233585, content=垃圾, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f196166226, createdName=ms9000001912630615, createdTime=Fri Feb 11 14:57:11 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191533, encodeId=28941191533df, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：很慢，基本历时9月余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf9a6160948, createdName=ms2000001136398144, createdTime=Wed Feb 09 21:27:23 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180906, encodeId=bb4f118090683, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤<br>经验分享：这个杂志超级垃圾 一审六个月 修一个月 二审一个月 二修一个月 拒了； 全程耗费一年，没有任何有意义的意见，建议各位老铁不要再投。是个垃圾不能再垃圾的杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95db5541159, createdName=阳关月, createdTime=Wed Jan 05 15:52:29 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179789, encodeId=51ea11e978932, content=European Review for Medical and Pharmacological Sciences这个专门卖文章的杂志都不预警，预警这个，收了多少钱，呵呵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05952206955, createdName=739976260_99249234, createdTime=Sun Jan 02 14:06:10 CST 2022, time=2022-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179462, encodeId=1f4c11e94621b, content=投了将近一个礼拜了稿号是MTNA-D-21-01775，状态还是submitted哎，上了预警名单，现在还能撤回嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Sat Jan 01 02:00:36 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179651, encodeId=2c5a11e965187, content=刚投一篇，under review已经1个月了，现在被预警了，好慌啊，也不知道要不要撤下来重新投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=517c5541105, createdName=齐小丹, createdTime=Sat Jan 01 22:23:53 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063270, encodeId=398010632e0d7, content=被吉大一院列为水刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Sat Oct 23 22:23:01 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179259, encodeId=c34c11e925988, content=进了今年的中科院高预警名单，哎，刚投的一篇还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Fri Dec 31 13:15:46 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2021-12-31 wsasdeffgcf

    进了今年的中科院高预警名单，哎，刚投的一篇还没消息

    2

    展开2条回复
共440条页码: 2/44页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分